Evidence map›Paper›PMID 41310857›Full record

ArticleJournal of hematology & oncology2025

Retraction Note: Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.

Deepika Kanojia, Manoj Garg, Jacqueline Martinez, Anand M T, Samuel B Luty, Ngan B Doan, Jonathan W Said, Charles Forscher, Jeffrey W Tyner, H Phillip Koeffler

Abstract readRetraction Notice
In one paragraph

Article in Journal of hematology & oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Deepika KanojiaCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csidk@nus.edu.sg.
Manoj GargCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Jacqueline MartinezCell, Developmental & Cancer, Oregon Health & Science University, Portland, OR, 97239, USA.
Anand M TCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Samuel B LutyCell, Developmental & Cancer, Oregon Health & Science University, Portland, OR, 97239, USA.
Ngan B DoanDepartment of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA, 90095, USA.
Jonathan W SaidDepartment of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA, 90095, USA.
Charles ForscherDivision of Hematology/Oncology, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles, CA, 90048, USA.
Jeffrey W TynerCell, Developmental & Cancer, Oregon Health & Science University, Portland, OR, 97239, USA.
H Phillip KoefflerCancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41310857
PMCPMC12659540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.